Market Cap

CRISPR Therapeutics AG Market Capitalization:

$4.82 Billion

USD as of Jan. 1, 2024

business CRISPR Therapeutics AG Company Profile

CRISPR Therapeutics AG Main Stock Listing

NASDAQ: CRSP

Market Capitalization History of CRISPR Therapeutics AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of CRISPR Therapeutics AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 $4.82 B 29.69%
Jan. 1, 2023 $3.72 B -25.95%
Jan. 1, 2022 $5.02 B -61.53%
Jan. 1, 2021 $13.04 B 218.96%
Jan. 1, 2020 $4.09 B 60.19%
Jan. 1, 2019 $2.55 B -17.44%
Jan. 1, 2018 $3.09 B 121.30%
Jan. 1, 2017 $1.40 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

CRISPR Therapeutics AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

CRISPR Therapeutics AG has the following listings and related stock indices.


Stock: NASDAQ: CRSP

Stock: BMV: CRSPN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.